Semaglutide
Compounded Injectable - 7 week supply
HomeKit with Telehealth Online Consult
$299
Monthly Pricing Only
(0.25mg, 0.5mg and 1mg dosing)
By mimicking this hormone (GLP-1), it targets the area of the brain that regulates our appetite and food consumption. It slows down stomach emptying, thus leaving you feeling fuller for a longer period of time. It also stimulates the secretion of insulin and slows the release of glucagon in your body, influencing blood sugar control.
​
Home Kit includes:
Compounded Semaglutide (1st vial contains 7 doses)
Subcutaneous Injection supplies
Rx Consultation [online]
Individualized Meal Plan
Shipping
​
​
*Current processing time is 3-5 business days
Semaglutide Pricing
Pricing includes online consultation, supplies, and shipping
Starting Vial
$299
4 doses 0f 0.25 mg + 3 doses of 0.5 mg - 7 week supply
Higher Dosing- 1.7 mg Weekly
$369
4-week supply
8-week supply - $599
2nd Order
$299
2 doses of 0.5 mg + 4 doses of 1 mg - 6-week supply
Max Dosing - 2.4 mg Weekly
$369
4-week supply
8-week supply $649
1 mg Weekly
$299
5-week supply
10-week supply $564
No Hidden Fees
No Membership Fees
No Extra Shipping Costs
No Recurring Payments
No Strings Attached
How Much Weight Can I Lose On Semaglutide?
On average, patients can expect to lose 1-4 lbs per week while on a therapeutic dose. Studies show that participants taking Semaglutide lost an average of almost 15% of their initial body weight over 68 weeks.
Am I a Good Candidate for Treatment with Semaglutide?
GLP-1 Agonists is for patients within the age of 18 to 75, with a body mass index (BMI) of greater than 30; or overweight, with a BMI greater than 27 accompanied by weight-related medical problems such as high blood pressure, type 2 diabetes, or high cholesterol.
​
You are NOT a good candidate if you have any of the following: diabetic retinopathy, low blood sugar, congestive heart failure, taking Warfarin, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2, pregnant or trying to get pregnant, breast-feeding, suicidal thoughts, plans, or attempt; a previous suicide attempt.
What is the Dosing?
Patients are started on the lowest dose to prevent gastrointestinal side effects. The typical titration schedule is as followed:
Starting dose: 0.25 mg once weekly Month 1
0.5 mg once weekly Month 2
1 mg once weekly Month 3
Optional: 1.7 mg once weekly Month 4
Optional: 2.4 mg once weekly Month 5 and onward
​
If you are currently on Semaglutide at another practice and would like to become a patient of ours, please click on "start my online visit", complete the intake form, and then activate your account in the email sent. Once your account is activated, you can upload documents in the Menu section. Upload a copy/picture of your current prescription, and your provider will review it. Picture must contain your full name, medication dosing and directions.
What are the Side Effects?
Possible side effects include irritation at injection site, fatigue, nausea, vomiting, heartburn, upset stomach, diarrhea, or constipation.
How is the Medication Administered?
It is administered as a subcutaneous injection (under the skin) once a week.
What Is the Difference Between Semaglutide and Tirzepatide?
Tirzepatide has shown to be more effective in weight loss. While both medications can lead to weight loss, there are key differences. Tirzepatide works similarly to other drugs in the GLP-1 agonist family, but it also contains a GIP receptor agonist, making it the first drug to imitate the two incretin hormones GIP/GLP-1. GIP has been shown to decrease food intake, boost insulin production, and lead to weight loss.
What are the Potential Risks?
It is important provide a thorough medical history to your provider before starting your weight loss journey. This medication should not be prescribed to individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), because there is an increased risk of developing thyroid C-cell tumors.
Other risks include:
-
Gallbladder problems, such as gallstones
-
Pancreatitis
-
Suicidal thinking or behavior
-
Diabetic retinopathy
-
Altered kidney function
Any Questions?
References: 1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807016/#:~:text=At%20week%20104%2C%20significantly%20more,weight%20(36.1%20vs%202.3%25). 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486455/
Shipping to FL, TX, AZ, NY, NJ, CT, MA, CO, WA, MD, NE, OR, KS, IA and UT